These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6450326)

  • 1. Characterization of immunoregulatory T cells in EBV-induced infectious mononucleosis by monoclonal antibodies.
    De Waele M; Thielemans C; Van Camp BK
    N Engl J Med; 1981 Feb; 304(8):460-2. PubMed ID: 6450326
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased numbers of cells with suppressor T cell phenotype in the peripheral blood of patients with infectious mononucleosis.
    Crawford DH; Brickell P; Tidman N; McConnell I; Hoffbrand AV; Janossy G
    Clin Exp Immunol; 1981 Feb; 43(2):291-7. PubMed ID: 6456093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
    Tosato G; Straus S; Henle W; Pike SE; Blaese RM
    J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants.
    Wallace LE; Moss DJ; Rickinson AB; McMichael AJ; Epstein MA
    Eur J Immunol; 1981 Sep; 11(9):694-9. PubMed ID: 6271557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G; Rickinson AB
    Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis using monoclonal antibodies of subpopulations of T-lymphocytes in infectious mononucleosis].
    Jordá Tormo J; Alvarez-Sala Walther JL; Arias Pérez JI; Alvarez Carmona A; Espinós Pérez D
    Med Clin (Barc); 1982 Sep 1-15; 79(4):181-4. PubMed ID: 6216377
    [No Abstract]   [Full Text] [Related]  

  • 7. EBV specific killer T cells and serologic responses after onset of infectious mononucleosis.
    Svedmyr E; Jondal M; Henle W; Weiland O; Rombo L; Klein G
    J Clin Lab Immunol; 1978 Nov; 1(3):225-32. PubMed ID: 228038
    [No Abstract]   [Full Text] [Related]  

  • 8. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
    Klein E; Ernberg I; Masucci MG; Szigeti R; Wu YT; Masucci G; Svedmyr E
    Cancer Res; 1981 Nov; 41(11 Pt 1):4210-5. PubMed ID: 6272964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis.
    Tosato G; Magrath I; Koski I; Dooley N; Blaese M
    N Engl J Med; 1979 Nov; 301(21):1133-7. PubMed ID: 226884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum migration inhibitory activity and monoclonal antibody-defined T-cell phenotypes in patients with acute infectious mononucleosis.
    Bertotto A; Gentili F; Stagni G; Zucchetti P; Vaccaro R
    Microbiologica; 1983 Jul; 6(3):221-7. PubMed ID: 6226848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control mechanisms in infectious mononucleosis.
    Denman AM; Pelton BK
    Clin Exp Immunol; 1974 Sep; 18(1):13-25. PubMed ID: 4377556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term T-cell-mediated immunity to Epstein-Barr virus.
    Rickinson AB; Moss DJ; Wallace LE; Rowe M; Misko IS; Epstein MA; Pope JH
    Cancer Res; 1981 Nov; 41(11 Pt 1):4216-21. PubMed ID: 6272965
    [No Abstract]   [Full Text] [Related]  

  • 13. [T- and B-lymphocyte determination in infectious mononucleosis].
    Sauer O
    Fortschr Med; 1977 Jun; 95(23):1506-8. PubMed ID: 328360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity spectrum and cell surface markers of mono- and multi-functional mixed leukocyte culture-derived T cell clones in man.
    Pawelec G; Kahle P; Wernet P
    Eur J Immunol; 1982 Jul; 12(7):607-15. PubMed ID: 6180909
    [No Abstract]   [Full Text] [Related]  

  • 15. CD8 lymphocytes during Epstein Barr virus (EBV) infection: A CD29 positive population is expanded in acute infectious mononucleosis.
    de Paoli P; Gennari D; Reitano M; Martelli P; Sacilotto C; Comoretto R; Santini G
    Allergol Immunopathol (Madr); 1991; 19(2):95-7. PubMed ID: 1722959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pattern of activation antigen expression on T-lymphocyte subpopulation in infectious mononucleosis.
    Pálóczi K; Pócsik E; Kotlán B; Ujhelyi E; Timár L; Petrányi GG
    Haematologia (Budap); 1991; 24(2):83-90. PubMed ID: 1840056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis.
    Tomkinson BE; Maziarz R; Sullivan JL
    J Immunol; 1989 Jul; 143(2):660-70. PubMed ID: 2472449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T- and B-cell subpopulations in infectious mononucleosis.
    Papamichail M; Sheldon PJ; Holborow EJ
    Clin Exp Immunol; 1974 Sep; 18(1):1-11. PubMed ID: 4549622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunoregulatory T-T cellular interactions in man].
    Taniguchi N
    Rinsho Ketsueki; 1984 Apr; 25(4):488-95. PubMed ID: 6332212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.